-
Miranda Lambert Leads North Texans with Seven Grammy Nominations for 2027
-
DiDi Advances Robotaxi Operations in China with New R2 Vehicle and Expanded Safety Infrastructure
-
Smart Car Seats Tested: Do Sensors and Apps Actually Improve Safety?
-
XPENG Launches Two New Models in UK; Pony.ai Robotaxi Enters Pilot
-
RuffleButts + RuggedButts Featured in Hasbro's 2026 Holiday Gift Guide
-
Dermata Highlights Additional Results and Photos from Cosmetic Study Evaluating Its Tome Foundational Treatment
-
NexCore and MetLife Investment Management Launch $1.3 Billion Senior Living Co-Investment Venture
-
Tectonic Metals Completes Record Drill Program at Flat, Advances Five Pillars of Growth Toward Major 2027 Milestones
-
Glidewell Opens Applications for 2027 Guiding Leaders Cohorts in California and North Carolina
-
International Business Times UK Increases Programmatic Revenue by 30% with Opti Digital
-
Valion Bio Reports Completion of 200-Liter Entolimod Production Run; Material Supplying Ongoing AFRRI Study
-
Miami Allstars FC have Applied to Compete in the Women's Premier Soccer League, with the Club Targeting a 2027 or 2028 Debut in North Miami, Florida
-
Klique Joins Lenovo AI Innovators, Bringing Its Enterprise AI Control Plane to Lenovo Hybrid AI Factory
-
Waste Energy to Host Shareholder Update Today at 4:30 PM EST; Management to Discuss WE #1 Commissioning, Revenue Opportunities and Growth Strategy
-
FaZe Esports, a GameSquare Company, Wins Rainbow Six Championship at Osaka Major
-
Pinnacle Food Group Limited Achieves Laboratory-Scale Astaxanthin Extraction in Haematococcus pluvialis Program
-
BioLargo Reports Third Quarter 2026 Results, Forecasting Commercial Breakout in 2027
-
Viking Global Technologies Announces Expansion of Grid Protection Technology Pilot with Another Major U.S. Electric Utility
-
Nexscient Reports Third Quarter 2026 Results; Revenue Rises Sequentially as Gross Margin Expands to Over 40%
-
TRNR Reports Record Q3 2026 Results, Driven by 66% Revenue Growth; M&A Pipeline Grows Significantly
-
Ur-Energy Commences Baseline Study Fieldwork; Nears Completion of Technical Report at Lost Soldier Uranium Project, Wyoming
-
How to Turn Your Garage into Usable Living Space
-
Pilot-Founded Solara Global Jet Offers Charter, Leases and Air Cargo Nationwide and Overseas
-
Driving Global Innovation - GTDC Summit APJ Underscores Distribution's Transformative Power
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 17
-
PRAAMS AI Co-Investor Now Covers 400,000+ Global Instruments, With Responses From 3 Seconds, Cost From US$0.01, and Scalability to Millions of Users
-
Broad Clinical Labs Drives Strong Digital Engagement by Connecting Customers with Published Research Through Bioz
-
Razavi Law Group Partners with Chapman University to Prepare the Next Generation of Attorneys
-
ImageWorks Display Advances Whole-Store Solutions with a Re-Imagined Planniq Strong and Planniq Chill
-
KIDZ AI Announces Strategic Collaboration with Synestria to Optimize AI Infrastructure Performance
-
Pivotree Announces Third Quarter 2026 Results
-
MedMira Receives U.S. FDA Breakthrough Device Designation for Its Multiplo(R) Complete Syphilis (TP/nTP) Antibody Test
-
Gabriel Resources Provides Corporate and Financing Update
-
HippoFi Achieves OTCID Market Designation, Opening a New Chapter of Commercial Growth
-
Galway Metals Intersects 1.8 g/t Gold Over 25.0 Metres and 0.7 g/t Gold Over 66.0 Metres at Clarence Stream
-
Avino Announces Key Technical Appointment
-
Brightline Interactive and TruWeather Solutions Sign MOU to Bring Weather Data into SpatialCore Physical AI Platform
-
Can Your Trash Can Pass the Holiday 'Eww' Test?
-
RMTG Expands Cellular Hope Institute's Cancún Clinical Facilities and Longevity Platform
-
Platinum Deck and Patio Announces Nashville, Tennessee Launch
-
Wedgewood Weddings Brings Creekside Mountain Celebrations to Idaho Springs with Blackstone Rivers
-
LIBRA Insurance Partners Welcomes Trawick Financial Services to Its Partner Network
-
FibreSeek Expands U.S. Availability of FibreSeeker 3 with Local Stock and Fulfillment
-
DASI Simulations Named to the 2026 CB Insights' 50 Most Promising Digital Health Startups
-
Islo Secures $15 Million Investment Led by Insight Partners to Scale Enterprise Software Factory Platform
-
Bluedrop Medical Appoints Mark Grant as CEO to Advance Commercialization and Strategic Growth
-
Join Nord Precious Metals' Live Investor Webinar: Advancing Silver Production and High-Grade Exploration in Ontario
-
Who Is the Best Plastic Surgeon in the Pacific Northwest?
-
BHG Financial Closes a New ABS Transaction of $495 Million
-
Spider Labs Upgrades YouTube Placement Exclusions in Spider AF
Modular Medical Announces First Human Use of MODD1 Pump Delivering Insulin
- Use of MODD1 on clinician with Type 1 diabetes
- Modular Medical intends to deploy the MODD1 on a larger number of clinicians in mid August
SAN DIEGO, CA / ACCESS Newswire / August 6, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target the estimated $3 billion dollar adult "almost-pumpers" market with its user-friendly and affordable design, today announced the first human use of the MODD1 pump to deliver insulin to a person with diabetes in a real-world setting. The MODD1 is delivering insulin to a clinician with Type 1 under institutional review board approval from the United States Food and Drug Administration, which is necessary because the reusable controller line is being validated for human use.
"This is another step in the maturation of the Modular Medical patch pump delivery platform. The pump controller module for MODD1 and the tubeless Pivot are identical, and the successful delivery of insulin has been a milestone we have anticipated since we began development," said Jeb Besser, CEO of Modular Medical.
Modular Medical intends to deploy its insulin units on multiple clinicians at multiple sites in a trial in the middle of August and looks forward to updating the market further on future developments.
Forward-Looking Statements
This press release contains forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statements contained in this press release. including but not limited to, the performance of the Company's products; expected deployments of the Company's pump product to persons with diabetes, the Company's ability to convert patients to use its MODD1 pump; the occurrence of future events or circumstances, successful development of Modular Medical's proprietary technologies, whether the market will accept Modular Medical's products and services, anticipated consumer demand for the Company's products, whether Modular Medical can successfully manufacture its products at high volumes, and general economic, and industry or political conditions in the United States or internationally, as well as other risk factors and business considerations described in Modular Medical's SEC filings, including its annual report on Form 10-K. Any forward-looking statements in this press release should be evaluated in light of these important risk factors. In addition, any forward-looking statements included in this press release represent Modular Medical's views only as of the date of its publication and should not be relied upon as representing its views as of any subsequent date. Modular Medical assumes no obligation to update these forward-looking statements, except as required by law.
About Modular Medical
Modular Medical, Inc. (Nasdaq: MODD) is a development-stage medical device company that intends to launch the next generation of insulin delivery technology. Using its patented technologies, the company seeks to eliminate the tradeoff between complexity and efficacy, thereby making top quality insulin delivery both affordable and simple to learn. Our mission is to improve access to the highest standard of glycemic control for people with diabetes taking it beyond "superusers" and providing "diabetes care for the rest of us."
Modular Medical was founded by Paul DiPerna, a seasoned medical device professional and microfluidics engineer. Prior to founding Modular Medical, Mr. DiPerna was the founder (in 2005) of Tandem Diabetes and invented and designed its t:slim insulin pump. More information is available at https://modular-medical.com.
All trademarks mentioned herein are the property of their respective owners.
CONTACT:
Jeb Besser
Chief Executive Officer
Modular Medical, Inc.
+1 (617) 399-1741
[email protected]
SOURCE: Modular Medical, Inc.
View the original press release on ACCESS Newswire
G.P.Martin--AT